FDA approves J&J's Invokana to treat Type 2 diabetes The U.S. Food and Drug Administration approved Johnson & Johnson's, Invokana, canaglifozin, tablets, used with diet and exercise, to improve glycemic control in adults with type 2 diabetes.
http://www.theflyonthewall.com/permalinks/entry.php/GILD;JNJid1808167/GILD;JNJ-Gilead-shares-likely-to-advance-through---says-RBC-Capital
http://www.theflyonthewall.com/permalinks/entry.php/GILD;JNJid1808167/GILD;JNJ-Gilead-shares-likely-to-advance-through---says-RBC-Capital
No comments:
Post a Comment